The FDA withdrew the emergency use authorization for AstraZeneca’s Covid antibody cocktail Evusheld because it does not work against omicron subvariant XBB.1.5
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld
You May Also Like
Pentagon drops Covid-19 vaccination mandate for troops
- January 11, 2023
The Pentagon formally dropped its Covid-19 vaccination mandate Tuesday, but a new memo signed by Defense Secretary Lloyd…
Justices participated in leak investigation, Supreme Court official confirms
- January 21, 2023
Supreme Court justices were interviewed by the official in charge of the probe into the leak of a…
Monterey Park left ‘looking for answers’ as police probe mass shooting
- January 23, 2023
Authorities were hunting for a motive on Monday after the deadly shooting at a dance hall in Monterey…
Ambitions collide as rising Democrats consider higher office – POLITICO
- March 5, 2023
Ambitions collide as rising Democrats consider higher office POLITICO
Is it too late now to buy ‘Sorry?’ Justin Bieber sells music back catalogue
- January 25, 2023
Justin Bieber has become the latest high-profile artist to sell his share of the rights to his music,…
Biden to unveil plan averting Medicare funding crisis, challenging GOP – The Washington Post
- March 7, 2023
Biden to unveil plan averting Medicare funding crisis, challenging GOP The Washington Post Biden wants to tax high-earners to…